TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RPRX

Royalty Pharma Plc

Healthcare · Biotechnology

58.90$ +0.8% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Royalty Pharma Plc (RPRX) with date, type and a link to the original document.

Filings RPRX
Date Type Filing Original
08/05/2026 Current report (8-K) Royalty Pharma plc (RPRX): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?